35,422
Views
98
CrossRef citations to date
0
Altmetric
Acceptance – Commentary

Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?

ORCID Icon, ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 1-3 | Received 28 Jan 2021, Accepted 16 Feb 2021, Published online: 08 Mar 2021

References

  • Wiysonge CS, Njamnshi AK, Nomo E, Shey MS. Eradication of poliomyelitis. Lancet. 2005;366(9492):1163–64. doi:10.1016/S0140-6736(05)67477-6.
  • Wiysonge CS, Nomo E, Mawo J, et al. Yellow fever control in Cameroon: where are we now and where are we going? BMC Med. 2008;6:3. doi:10.1186/1741-7015-6-3.
  • LaForce FM, Okwo-Bele JM. Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine. Health Affairs (Project Hope). 2011;30(6):1049–57. doi:10.1377/hlthaff.2011.0328.
  • Okwo-Bele JM, Cherian T. The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine. 2011;29(Suppl 4):D74–9. doi:10.1016/j.vaccine.2012.01.080.
  • WHO. COVID-19 response. Agenda item 3; WHA73.1; Seventy-third World Health Assembly. 19 May 2020. 2020. [accessed 2021 January 25]. https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_R1-en.pdf.
  • Anonymous. Three in four adults globally say they would get a vaccine for COVID-19. 2020. [accessed 2021 January 25]. https://www.ipsos.com/en-za/three-four-adults-globally-say-they-would-get-vaccine-covid-19.
  • AfricaCDC. Majority of Africans would take a safe and effective COVID-19 vaccine. 17 December 2020. 2020. (accessed 2021 January 25]. https://africacdc.org/news-item/majority-of-africans-would-take-a-safe-and-effective-covid-19-vaccine/.
  • Wiyeh AB, Cooper S, Jaca A, Mavundza E, Ndwandwe D, Wiysonge CS. Social media and HPV vaccination: unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa. Vaccine. 2019;37:6317–23. doi:10.1016/j.vaccine.2019.09.019.
  • Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Global Health. 2020;5(10):e004206. doi:10.1136/bmjgh-2020-004206.
  • Cooper S, Betsch C, Sambala EZ, Mchiza N, Wiysonge CS. Vaccine hesitancy – a potential threat to the achievements of vaccination programmes in Africa. Hum Vaccin Immunother. 2018.
  • Betsch C, Bach Habersaat K, Deshevoi S, Heinemeier D, Briko N, Kostenko N, Kocik J, Böhm R, Zettler I, Wiysonge CS, et al. Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination. BMJ Open. 2020;10(3):e034869. doi:10.1136/bmjopen-2019-034869.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018;13(12):e0208601. doi:10.1371/journal.pone.0208601.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228. doi:10.1038/s41591-020-1124-29.
  • WHO. An ad hoc WHO technical consultation managing the COVID-19 infodemic: call for action. Geneva (Switzerland):World Health Organization; 2020 April 7-8. 2020. Licence: CC BY-NC-SA 3.0 IGO. 2020.[accessed 2021 January 25]. https://www.who.int/publications/i/item/9789240010314.
  • Wiyeh AB, Cooper S, Nnaji CA, Wiysonge CS. Vaccine hesitancy ‘outbreaks’: using epidemiological modeling of the spread of ideas to understand the effects of vaccine related events on vaccine hesitancy. Expert Rev Vaccines. 2018;17(12):1063–70. doi:10.1080/14760584.2018.1549994.
  • Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: A systematic review. Hum Vaccin Immunother. 2018;14(7):1599–609. doi:10.1080/21645515.2018.1459252.
  • Sambala EZ, Cooper S, Manderson L. Ubuntu as a framework for ethical decision making in Africa: responding to epidemics. Ethics Behav. 2020;30(1):1–13. doi:10.1080/10508422.2019.1583565.
  • Cooper S, Okeibunor JC, Wiyeh A, Wiysonge CS. Knowledge advances and gaps on the demand side of vaccination. Lancet Infect Dis. 2019;19(1):13–15. doi:10.1016/S1473-3099(18)30733-3.
  • Dubé E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P. Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies. Expert Rev Vaccines. 2018;17(11):989–1004. doi:10.1080/14760584.2018.1541406.
  • Cooper S, Schmidt BM, Sambala EZ, Swartz A, Colvin CJ, Leon N, Betsch C, Wiysonge CS. Factors that influence parents’ and informal caregivers’ acceptance of routine childhood vaccination: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2019;2:CD013265. doi:10.1002/14651858.CD013265.
  • Oduwole EO, Pienaar ED, Mahomed H, Wiysonge CS. Current tools available for investigating vaccine hesitancy: a scoping review protocol. BMJ Open. 2019;9(12):e033245. doi:10.1136/bmjopen-2019-033245.
  • WHO. Meeting report of the measuring behavioural and social drivers (BeSD) of vaccination working group. Geneva (Switzerland): World Health Organization; 2019 May 1–3 [accessed 26 January 2021]. https://www.who.int/immunization/programmes_systems/Meeting_report_May2019.pdf?ua=1.
  • Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149–207. doi:10.1177/1529100618760521.